WellAir has launched the Defend NV 400, an FDA-cleared Class II medical device that is 99.9% effective at inactivating airborne pathogens such as the SARS-CoV-2 proxy virus (MS2 bacteriophage), MRSA, bacteria and fungi, and also purifies the air of particulate matter, VOCs, gases and odors.
Features WellAir’s patented NanoStrike technology, which bursts airborne pathogen cells to rapidly inactivate them and ensure they are no longer a threat. Utilizes medical-grade filters from Camfil to capture bacterial debris, fine and large particles, VOCs, gases, odors and other impurities.